ALPINE GROUP PARTNERS, LLC.

Lobbying for COUNCIL ON RADIONUCLIDES AND RADIOPHARMACEUTICALS

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 17, 2025

Lobbying activity 2

Health Issues

Issues regarding the reimbursement of radiopharmaceuticals Tariffs and supply chain issues

Medicare/Medicaid

Issues regarding the reimbursement of radiopharmaceuticals Tariffs and supply chain issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.